<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2022</study_start_year><data_sharing_plan>IPD Sharing (as of June 2022): No</data_sharing_plan><condition>Cancer Colon</condition><condition>Colorectal Neoplasms</condition><condition>Anaemia with colorectal cancer</condition><disease>Anaemia With Colorectal Cancer</disease><disease>Cancer Colon</disease><disease>Colorectal Neoplasms</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2399886</full_dataset_link><location>United Kingdom</location><study_start_month>5</study_start_month><keyword>Ferric maltol</keyword><repository>ECRIN MDR</repository><study_status>Recruiting</study_status></additional><is_claimable>false</is_claimable><name>Perioperative Iron for Colorectal Cancer (PICoC Study)</name><description>The PICoC study aims to investigate whether oral ferric maltol given postoperatively offers an improvement in patient and clinician reported outcomes compared to standard care.</description><dates><creation>2022-05-15</creation></dates><accession>2399886</accession><cross_references><ClinicalTrials___gov>NCT05177484</ClinicalTrials___gov><EU Clinical Trials Register>2021-006004-32</EU Clinical Trials Register><ISRCTN>ISRCTN12290106</ISRCTN></cross_references></HashMap>